Add Row
Add Element
cropper
update
[Company Name]
Concierge Health Hub logo
update
Add Element
  • Home
  • Categories
    • Practice Mastery
    • Patient Connect
    • Financial Fitness
    • Tech Advantage
    • Marketing Mastery
    • Regulatory Radar
    • Wellness Wisdom
Add Row
Add Element
June 06.2025
2 Minutes Read

How TEVs-TTN Revolutionizes Understanding Mechanical Proteins and Muscular Disorders

How TEVs-TTN Revolutionizes Understanding Mechanical Proteins and Muscular Disorders


Exploring the Role of Mechanical Proteins in Muscle Health

Recent advancements in biomedical research have unveiled a groundbreaking method for studying mechanical proteins, specifically titin, and their crucial role in muscular health. Research conducted by the Centro Nacional de Investigaciones Cardiovasculares (CNIC) reveals an innovative approach known as TEVs-TTN, which permits the targeted cleavage of titin in animal models. This development offers a new lens through which practitioners can understand the intricacies of muscular disorders and opens avenues for potential therapeutic interventions.

Understanding Titin and Its Impact on Muscle Function

Titin, the largest protein in the human body, plays an integral role in maintaining the structure of sarcomeres—the fundamental contractile units of muscle tissue. Mutations in the TTN gene lead to a range of muscular disorders, such as congenital muscular diseases and cardiomyopathies. By utilizing TEVs-TTN, researchers can simulate the functional impairments caused by truncated titin proteins, providing insights into the cellular consequences of these mutations. The knowledge gained from this study is vital for health practitioners who may encounter patients affected by titin mutations.

The Significance of TEVs-TTN in Muscular Disease Research

The TEVs-TTN methodology not only enhances the understanding of how mutations disrupt muscle function, but also serves as a practical tool for experimental trials. As highlighted by first author Dr. Roberto Silva-Rojas, this controlled cleavage of titin replicates the structural disorganization seen in patients, including cell-volume reduction and mitochondrial dysfunction. This replicated model allows physicians and researchers to evaluate potential therapies aimed at restoring sarcomere integrity and improving patient outcomes.

Real-world Relevance and Implications for Patient Care

The implications of this research extend beyond the lab. For concierge health practitioners, staying informed about emerging studies like TEVs-TTN can inform patient assessments and treatment strategies. Knowledge of the mechanisms underlying muscular disorders provides a foundation for tailoring interventions and enhancing patient outcomes. As the acute and chronic effects of muscle degradation become clearer, practitioners will be better equipped to guide their patients through effective management strategies.

Potential Future Directions in Muscular Disorder Treatments

This innovative technique promises to pave the way for targeted therapies that can alleviate the consequences of muscular diseases linked to titin. As this research unfolds, new therapeutic strategies may emerge—an essential development for practitioners keen to stay ahead in an ever-evolving healthcare landscape.

Conclusion: Empowering Patient Care with Evidence-Based Insights

The breakthroughs at CNIC highlight the importance of integrating advanced research into clinical practice. For those in concierge health, embracing these insights facilitates informed decisions and enhances patient care. By understanding the mechanics of muscle diseases, practitioners can create tailored management plans that address the unique needs of their patients. Stay engaged with ongoing research in this area to ensure you are providing the best possible care.

As the field advances, consider advocating for your patients' involvement in clinical trials or monitoring for new therapeutic options emerging from research like that of TEVs-TTN. By prioritizing education and awareness in your practice, you can significantly impact your patients' health outcomes.


Tech Advantage

Write A Comment

*
*
Related Posts All Posts
06.08.2025

Canid's $10M Funding Revolutionizes Pediatric Vaccine Management for Growing Practices

Update Understanding the Financial Strain in Pediatric PracticesPediatric practices are experiencing escalating financial pressures, with vaccination programs becoming a primary source of strain. Despite their critical importance, many pediatricians find themselves either breaking even or operating at a loss. A staggering 69% of these practices face challenges due to insurance reimbursements and complex inventory management. This financial burden is compounded by increasing administrative tasks, necessitating an innovative approach to vaccine management.Canid's Innovative Solution for Pediatric Vaccine ManagementCanid, founded in 2021, has positioned itself as a game-changer in this landscape. By securing $10 million in Series A funding, the company aims to relieve the overwhelming administrative and financial burden on independent pediatricians. The company focuses on streamlining vaccine management, which often represents the second-largest expense for these practices, only coming behind staff salaries. With over 150 pediatricians already utilizing its platform, Canid has facilitated vaccinations for 121,000 patients across twelve states, demonstrating a robust early success in its mission.Why Automation is Key to Reducing BurnoutOne of the significant issues faced by pediatricians is burnout, exacerbated by the administrative tasks tethered to patient care. Currently, pediatricians spend an average of 15 hours per week managing non-clinical activities. Canid seeks to alleviate this burden through its automated platform that integrates seamlessly with electronic health records (EHR). By scanning a vaccine barcode, pediatricians can offload their administrative tasks—ranging from ordering and billing to compliance with public health standards.Empowering Pediatricians with Data-Driven InsightsThrough data-driven patient outreach, Canid equips practitioners with insights into their patient panels, enhancing vaccination completion rates. The platform leverages AI and automation to track undervaccinated children, thereby addressing public health challenges effectively. As Canid CEO Pedro Sánchez de Lozada states, "Pediatricians spend years training to provide exceptional care for children, not to become experts in revenue cycle management or inventory systems." This philosophy underlines Canid’s goal: to let pediatricians concentrate on their core mission of caring for children.The Future of Pediatric Care: A Vital ShiftAs the healthcare landscape shifts toward consolidation, independent pediatric practices must adopt innovative solutions to thrive amid challenges. Canid’s significant investment paves the way for pediatricians to regain control over their financial health and operational efficiency. In the coming years, as more practices adopt such technologies, we could witness a revitalization of independent pediatric care in America, potentially leading to better health outcomes for children and families.Actionable Steps for Practice GrowthFor independent pediatric practitioners looking to enhance their operations, embracing technology like Canid's platform is not just beneficial—it is essential. Consider conducting a thorough assessment of your practice's current vaccine management strategies and identifying areas that could benefit from automation. Engaging with platforms that offer streamlined administrative solutions can significantly increase efficiency, reduce burnout, and ultimately lead to better patient care.Conclusion: The Importance of Tech in Pediatric PracticesThe significance of Canid’s platform in the realm of pediatric care cannot be understated. By addressing the financial and administrative challenges faced by independent practices, Canid presents a transformative opportunity for pediatricians. As technology continues to evolve, embracing these innovations will not only support practice sustainability but also enhance the quality of care delivered to young patients.

06.08.2025

Omada Health's NASDAQ Debut: A Game Changer for Digital Health Investors

Update Understanding Omada Health's Success: A Strategic Overview Omada Health's recent debut on NASDAQ illustrates a crucial turning point in the digital health landscape, bolstering investor confidence after a wavering market for IPOs. Busting through the initial offering price of $19 to a robust $23 per share, the company signifies a resurgence in investor appetite for digital health entities—especially those that demonstrate scale, revenue growth, and innovative strategies amid ongoing healthcare challenges. Solving Chronic Disease: An Emerging Need With chronic diseases consuming an astonishing $526 billion annually in the U.S., Omada Health's specific focus on addressing these conditions has broad ramifications. Their virtual-first model serves over a million lifetime members and 2,000 enterprise customers, aiming to significantly mitigate the repercussions of obesity, diabetes, and cardiovascular issues. This direct engagement positions them uniquely in a market plagued by traditional healthcare delivery hurdles, and it aligns well with the demand for cost-effective solutions. Innovative Approaches: GLP-1 Strategy Unlike many competitors focused solely on prescribing GLP-1 weight-loss drugs, Omada has established a unique path by integrating behavior change programs tailored for patients using these medications. This comprehensive approach works alongside conventional prescriptions, equipping patients with personalized support in lifestyle management, nutrition, and adherence strategies. Such innovation not only enhances the patient experience but also appeals to major payers and pharmacy benefit managers, adding a substantial layer of financial viability to their model. Leveraging AI for Personalized Care In an era where technology shapes healthcare delivery, Omada Health is successfully incorporating artificial intelligence into its services. Their recent launch of an AI-driven tool for nutritional tracking, ‘OmadaSpark’, exemplifies this dedication. Members receive immediate guidance and support, enhancing user engagement and fostering adherence to healthier lifestyles. This intelligent design underscores how tech integration can lead to better health outcomes, a prospect that provides peace of mind to both patients and health practitioners. The Financial Landscape: Significance of Growth As Omada's revenue ascended by an impressive 57% in the first quarter of 2025, reaching $55 million, it clarified the company’s forward momentum. Incremental financial discipline alongside growth—evidenced by significantly reduced net losses—demonstrates a clear pathway to profitability, a crucial factor attracting investors back into the sector. Such financial health positions Omada to lead initiatives compelling for concierge health practitioners navigating their own growth challenges. The Broader Implications for the Digital Health Sector Omada’s IPO should be viewed as a bellwether for a wider recovery in digital health. Following a quiet phase for public exits, the successful launches of Omada and Hinge Health signal that investor confidence is returning to a market eager for scalable solutions addressing urgent healthcare needs. This is an essential signal for practitioners seeking avenues to integrate technology within their practices while remaining committed to patient-centric care. What This Means for You: Embracing Change As new technologies emerge and the healthcare landscape evolves, staying updated with trends like those seen with Omada's trajectory is vital for concierge health practitioners. Integrating technology can provide streamlined efficiencies, better patient engagement, and enhanced care delivery—critical elements for sustaining a competitive edge in the community. Understanding how to leverage these changes can ease feelings of being overwhelmed by the tech side of your practice. Conclusion: Future Outlook in Digital Health The successful IPO of Omada serves not just as a marker of its own triumph, but as a trajectory for the future of digital health. As practitioners, refining strategies for technology integration now becomes paramount. The signs are clear: understanding and leveraging these market dynamics can support practice growth and optimize patient connections. With healthcare's trajectory towards virtual-first care solidifying, the opportunity for a harmonious blend of technology and patient engagement stands ripe for the taking. Engaging with these innovations can mean profound improvements in practice management and patient satisfaction.

06.08.2025

D-Sorbitol: The Sweet Solution Transforming Medical Hydrogels and Implants

Update The Sweet Revolution in Medical Hydrogels Imagine a future where treating chronic illnesses becomes less about swallowing pills and more about integrating soft, flexible electronic implants into our bodies. This potential reality is closer than we think, thanks to recent advancements in medical technology and a surprisingly sweet ingredient. Recent research led by Dr. Limei Tian at Texas A&M University has uncovered the potential of using D-sorbitol—a safe sugar alternative found in chewing gum—to replace toxic additives traditionally used in conductive hydrogels. These materials are crucial for the function of electronic implants, which are increasingly utilized to diagnose and treat a variety of diseases. What Are Conductive Hydrogels? Conductive hydrogels are soft materials that can mimic the mechanical properties of human tissues. They are designed to enhance the performance of electronic implants, improving their electrical conductivity and flexibility. Current bioelectronic devices have several limitations, primarily due to the use of harmful additives that can lead to negative side effects for patients. Hydrogels made from D-sorbitol provide a promising alternative that is both biocompatible and effective. How D-Sorbitol Enhances Implant Efficiency D-sorbitol not only enhances the hydrogels' electrical properties but also offers greater comfort and compatibility with the body's natural tissues. Dr. Tian noted, "These devices could revolutionize treatments for neurological disorders, paralysis, and chronic pain, making long-term implants more viable and effective." The flexibility of D-sorbitol-based hydrogels means they can adapt to bodily movement, reducing the risk of immune rejection and improving patient outcomes. Potential Applications of Enhanced Hydrogels The applications for these innovative hydrogels extend far beyond neurological devices. They hold promise for: Brain Implants: For disorders such as Parkinson's disease or epilepsy, where precision is key. Nerve Interfaces: To restore movement in patients with spinal cord injuries, bridging the gap between technology and biological function. Wearable Biosensors: For continuous health monitoring, providing real-time feedback about a patient’s well-being. Electronic Skin: Enhancing prosthetics with increased sensory feedback, making them feel more “natural” to the user. Soft Robotics: Incorporating touch sensitivity, which is vital for creating adaptive robotic systems. The Road Ahead: Potential and Challenges While the possibilities are exciting, challenges remain. Creating a conductive hydrogel that maintains biocompatibility over time is crucial. Many current implants trigger immune responses leading to tissue scarring. By leveraging the biocompatible properties of D-sorbitol, researchers aim to mitigate these adverse effects, transforming how we approach implantable electronics. Best Practices for Health Practitioners As this technology advances, health practitioners should consider: Staying informed about new materials and additives that could enhance patient care. Examining existing implant technologies for potential upgrades that could improve patient safety and comfort. Discussing with patients the latest treatment options that may arise from these technological advancements. Overall, it’s clear that D-sorbitol could herald a new era in medical treatments, one where the intersection of technology and biology improves patient outcomes and enhances the quality of life. Conclusion: The Sweet Potential of Hydrogels The successful integration of D-sorbitol in conductive hydrogels represents a significant step towards safer, more effective medical implants. If you’re a healthcare provider, keep an eye on these developments, as they could reshape the treatment options available to your patients.

Add Row
Add Element
cropper
update
MYBRANDINGLOGO
Concierge Health Hub logo
update

Concierge Health Hub is a popular free resource for concierge medical practices in the English-speaking world, providing insights into everything from connecting with your patients, to marketing, to regulatory rules.

  • Concierge Health Hub Facebook Page URL
    update
  • update
  • update
  • update
  • update
  • update
  • update
Add Element

NEED TO CONTACT US?

If you have any enquiries, contact us now and we will get back to you as soon as possible.

Setup Your Button

   CONTACT US   

{"name":"Contact Us","action_type":"2","optin_action_type":"5","form_redirect_type":"2","form_redirect_custom_url":"","order_form_settings":{"containers":[{"id":"personal-info-wrapper","visible":true,"label":{"id":"of-personal-title","visible":true},"fields":[{"id":"of-full-name","setting":false,"placeholder":"Full Name"},{"id":"of-field-email","setting":false,"placeholder":"Email Address"},{"id":"of-phone-number","setting":true,"visible":false,"require":true,"placeholder":"Enter Your Mobile Phone","additional":{"sms_permission":0}},{"id":"of-gdpr-optin-approval","label":"I Accept To Receive Additional Info","placeholder":"","icon":"fa-mobile","required":0,"visible":0,"system":1,"additional":{"gdpr_optin_approval":"1"}}]},{"id":"shipping-information-wrapper","visible":false,"label":{"id":"of-shipping-title","visible":true},"fields":[{"id":"of-shipping-address","setting":false,"placeholder":"Address"},{"id":"of-shipping-city","setting":false,"placeholder":"City"},{"id":"of-shipping-state","setting":false,"placeholder":"State"},{"id":"of-shipping-zipcode","setting":false,"placeholder":"Postal Code"}]},{"id":"profit-bump-wrapper","visible":true,"otoBgColor":"rgba(219,229,239,1)","otoBorderColor":"rgba(38,71,102,1)","otoTitleBgColor":"rgba(45,78,108,1)","otoArrowsColor":"rgba(255,177,58,1)","fields":[]},{"id":"order-summary-wrapper","visible":true,"orderDynamicBgColor":"rgba(242,242,242,1)","orderDynamicTexColor":"rgba(51,51,51,1)","fields":[]}]},"optin_type":{"showLabels":0,"fields":[{"name":"first_name","label":"Full Name","placeholder":"Enter Your Full Name","icon":"fa-user","required":1,"visible":1,"system":1,"additional":{}},{"name":"last_name","label":"Full Name","placeholder":"Enter Your Full Name","icon":"fa-user","required":1,"visible":1,"system":1,"additional":{}},{"name":"email","label":"Email","placeholder":"Enter Your Email","icon":"fa-envelope","required":1,"visible":1,"system":1,"additional":{}},{"name":"mobile_phone","label":"Mobile Phone","placeholder":"Enter Your Mobile Phone","icon":"fa-mobile","required":0,"visible":0,"system":1,"additional":{"sms_permission":0}},{"name":"fields_labels","label":"","placeholder":"","icon":"","required":0,"visible":1,"system":1,"additional":{}},{"name":"captcha","label":"Captcha","placeholder":"","icon":"","required":1,"visible":1,"system":1,"additional":{}},{"name":"gdpr_optin_approval","label":"SSBBY2NlcHQgVG8gUmVjZWl2ZSBBZGRpdGlvbmFsIEluZm8=","placeholder":"","icon":"fa-mobile","required":0,"visible":1,"system":1,"additional":{"gdpr_optin_approval":"1","sms_permission":0}}],"customFields":[],"sortedFields":[{"name":"first_name","label":"Full Name","placeholder":"Enter Your Full Name","icon":"fa-user","required":1,"visible":1,"system":1,"additional":{}},{"name":"first_name","label":"Full Name","placeholder":"Enter Your Full Name","icon":"fa-user","required":1,"visible":1,"system":1,"additional":{}},{"name":"last_name","label":"Full Name","placeholder":"Enter Your Full Name","icon":"fa-user","required":1,"visible":1,"system":1,"additional":{}},{"name":"email","label":"Email","placeholder":"Enter Your Email","icon":"fa-envelope","required":1,"visible":1,"system":1,"additional":{}},{"name":"mobile_phone","label":"Mobile Phone","placeholder":"Enter Your Mobile Phone","icon":"fa-mobile","required":0,"visible":0,"system":1,"additional":{"sms_permission":0}},{"name":"captcha","label":"Captcha","placeholder":"","icon":"","required":1,"visible":1,"system":1,"additional":{}}],"design":{"form_background_color":"rgb(245, 245, 245)","field_stroke":{"size":"1","color":"rgb(220, 220, 220)"},"field_icons":1,"button_color":"rgb(255, 158, 0)","button_stroke":{"size":"0","color":"rgba(255, 255, 255, 0.2)"},"button_box_shadow_color":"none","field_size":"small","label_size":"16","label_color":"rgb(0, 0, 0)","input_color":"rgb(52, 152, 219)","control_text_color":"rgb(0, 0, 0)","control_text_size":"15"},"mappedFields":[]},"redirect_type":{"url":"","target":0},"next_step":{},"click_to_email":{"value":"info@banidadigital.com"},"click_to_call":{"value":""},"jump_to_block":{},"content":{"header_text":"PHNwYW4gc3R5bGU9ImZvbnQtc2l6ZToyNHB4OyBmb250LWZhbWlseTonb3BlbiBzYW5zJzsiPjxzcGFuIHN0eWxlPSJsaW5lLWhlaWdodDoxLjRlbTsiPldlIEFyZSBFeGNpdGVkITwvc3Bhbj48L3NwYW4+","content_text":"PHNwYW4gc3R5bGU9ImZvbnQtc2l6ZTo0OHB4OyBmb250LWZhbWlseTonb3BlbiBzYW5zJzsiPjxzcGFuIHN0eWxlPSJsaW5lLWhlaWdodDowLjllbTsiPjxzdHJvbmc+UExFQVNFIEZJTEwgT1VUIFlPVVIgSU5GTyAgQkVMT1cgVE8gU1VCU0NSSUJFPC9zdHJvbmc+PC9zcGFuPjwvc3Bhbj4=","button_text":"PHNwYW4gc3R5bGU9ImZvbnQtc2l6ZToyN3B4OyBmb250LWZhbWlseTonb3BlbiBzYW5zJzsiPjxzcGFuIHN0eWxlPSJsaW5lLWhlaWdodDoxZW07Ij48c3Ryb25nPlNFQ1VSRSBNWSBTUE9UPC9zdHJvbmc+PC9zcGFuPjwvc3Bhbj4=","spam_text":"PHNwYW4gc3R5bGU9ImxpbmUtaGVpZ2h0OjEuMmVtOyI+V2UgaGF0ZSBTUEFNIGFuZCBwcm9taXNlIHRvIGtlZXAgeW91ciBlbWFpbCBhZGRyZXNzIHNhZmU8L3NwYW4+","sms_text":"UmVjZWl2ZSBTTVMgVGV4dCBVcGRhdGVzIC0gPHNwYW4+b3B0aW9uYWw8L3NwYW4+","sms_text2":"SSBBY2NlcHQgVG8gUmVjZWl2ZSBBZGRpdGlvbmFsIEluZm8="},"email_confirmation":{"enable":1,"subject":"V2UgQXJlIEV4Y2l0ZWQhIFlvdXIgSW4h","message":""},"integrations":[],"automation_enable":0,"thank_you":{"type":"popup","redirect_url":"","popup_options":{"background_color":"#ffffff","headline_visible":1,"icon_visible":1,"icon_url":"//my.funnelpages.com/assets-pb/images/thankyou-popup-icon.png","subheadline_visible":1,"button_visible":1,"button_color":"#ffa800","headline_text":"PHNwYW4gc3R5bGU9ImxpbmUtaGVpZ2h0OjEuNGVtOyI+VGhhbmsgWW91IEZvciBDb250YWN0aW5nIFVzPC9zcGFuPg==","subeadline_text":"PHNwYW4gc3R5bGU9ImxpbmUtaGVpZ2h0OjEuNGVtOyI+UGxlYXNlIENoZWNrIFlvdXIgRW1haWw8YnIgLz5XZSBXaWxsIEJlIEZvbGxvd2luZyBVcCBTaG9ydGx5PC9zcGFuPg==","button_text":"Q2xvc2U="}}}
Add Element

© 2025 Alicorn Ventures, LLC All Rights Reserved. 30 N. Gould Ste R, Sheridan, WY 82801 . Contact Us . Terms of Service . Privacy Policy

{"company":"Alicorn Ventures, LLC","address":"30 N. Gould Ste R","city":"Sheridan","state":"WY","zip":"82801","email":"info@banidadigital.com","tos":"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","privacy":"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"}

Terms of Service

Privacy Policy

Core Modal Title

Sorry, no results found

You Might Find These Articles Interesting

T
Please Check Your Email
We Will Be Following Up Shortly
*
*
*